A research project led by The University of Western Australia in collaboration with Telethon Kids Institute and 13 health research organisations has identified key differences between cancers that respond to immunotherapy and those that do not. The breakthrough, which has the potential to improve cancer treatment, is published in the journal Science Translational Medicine. Immunotherapy treatment… Read More »
The incidence of brain trauma has been rising in recent years. According to the Centers for Disease Control and Prevention (CDC), emergency department visits related to traumatic brain injury (TBI) increased by 53 percent in the U.S. from 2006 to 2014. For 2014 alone, the CDC reported about 2.87 million TBI-related visits, hospitalizations, and deaths.… Read More »
Behavioral chronic migraine treatment such as relaxation training, hypnosis and biofeedback makes financial sense in comparison to prescription medication, particularly after a year or longer. The costs of prescription medications, the type chronic migraine sufferers use on a daily basis in order to prevent onset, might not appear to be much even at a few… Read More »
According to Rutgers researchers, physicians are scaling back on prescribing antibiotics for long-term acne treatment in favour of a combination of therapies. Prolonged use of antibiotics can affect the microbiome (the trillions of bacteria, viruses and fungi that inhabit our bodies) in areas other than the skin, resulting in disease. The Rutgers report noted that… Read More »
Print this page KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC) who are not… Read More »